Banner_top
Frame_top

DF/HCC "Pipelines in Oncology" Seminar - TetraLogic Pharmaceuticals


Date: February 21, 2013 12:30 PM - 02:00 PM

Location: Dana Farber Cancer Institute, 450 Brookline Ave, Yawkey 306

Contact: richard_power@dfci.harvard.edu

Documents:

Description:

TetraLogic Senior Scientists will present on Birinapant, their lead Smac mimetic drug. We will hear from:

David Weng, MD, PhD, Senior Vice President and Chief Medical Officer

Martin Graham, PhD, VP of Development

Stephen M. Condon, PhD, VP of Chemistry

Srinivas Chunduru, PhD, Sr. Director of Biology

 

Back